186 related articles for article (PubMed ID: 28467780)
1. Novel transcription-induced fusion RNAs in prostate cancer.
Zhao S; Løvf M; Carm KT; Bakken AC; Hoff AM; Skotheim RI
Oncotarget; 2017 Jul; 8(30):49133-49143. PubMed ID: 28467780
[TBL] [Abstract][Full Text] [Related]
2. SLC45A3-ELK4 is a novel and frequent erythroblast transformation-specific fusion transcript in prostate cancer.
Rickman DS; Pflueger D; Moss B; VanDoren VE; Chen CX; de la Taille A; Kuefer R; Tewari AK; Setlur SR; Demichelis F; Rubin MA
Cancer Res; 2009 Apr; 69(7):2734-8. PubMed ID: 19293179
[TBL] [Abstract][Full Text] [Related]
3. Androgen regulation of ETS gene fusion transcripts in prostate cancer.
Gasi D; Trapman J
Methods Mol Biol; 2011; 776():335-48. PubMed ID: 21796535
[TBL] [Abstract][Full Text] [Related]
4. Chimeric transcript generated by cis-splicing of adjacent genes regulates prostate cancer cell proliferation.
Zhang Y; Gong M; Yuan H; Park HG; Frierson HF; Li H
Cancer Discov; 2012 Jul; 2(7):598-607. PubMed ID: 22719019
[TBL] [Abstract][Full Text] [Related]
5. SLC45A3-ELK4 functions as a long non-coding chimeric RNA.
Qin F; Zhang Y; Liu J; Li H
Cancer Lett; 2017 Sep; 404():53-61. PubMed ID: 28716526
[TBL] [Abstract][Full Text] [Related]
6. Discovery of CTCF-sensitive Cis-spliced fusion RNAs between adjacent genes in human prostate cells.
Qin F; Song Z; Babiceanu M; Song Y; Facemire L; Singh R; Adli M; Li H
PLoS Genet; 2015 Feb; 11(2):e1005001. PubMed ID: 25658338
[TBL] [Abstract][Full Text] [Related]
7. Fusion transcript loci share many genomic features with non-fusion loci.
Lai J; An J; Seim I; Walpole C; Hoffman A; Moya L; Srinivasan S; Perry-Keene JL; ; Wang C; Lehman ML; Nelson CC; Clements JA; Batra J
BMC Genomics; 2015 Dec; 16():1021. PubMed ID: 26626734
[TBL] [Abstract][Full Text] [Related]
8. Transcription-mediated chimeric RNAs in prostate cancer: time to revisit old hypothesis?
Ren G; Zhang Y; Mao X; Liu X; Mercer E; Marzec J; Ding D; Jiao Y; Qiu Q; Sun Y; Zhang B; Yeste-Velasco M; Chelala C; Berney D; Lu YJ
OMICS; 2014 Oct; 18(10):615-24. PubMed ID: 25188740
[TBL] [Abstract][Full Text] [Related]
9. Fusion transcript detection using spatial transcriptomics.
Friedrich S; Sonnhammer ELL
BMC Med Genomics; 2020 Aug; 13(1):110. PubMed ID: 32753032
[TBL] [Abstract][Full Text] [Related]
10. InFusion: Advancing Discovery of Fusion Genes and Chimeric Transcripts from Deep RNA-Sequencing Data.
Okonechnikov K; Imai-Matsushima A; Paul L; Seitz A; Meyer TF; Garcia-Alcalde F
PLoS One; 2016; 11(12):e0167417. PubMed ID: 27907167
[TBL] [Abstract][Full Text] [Related]
11. Characterization of TMPRSS2:ETV5 and SLC45A3:ETV5 gene fusions in prostate cancer.
Helgeson BE; Tomlins SA; Shah N; Laxman B; Cao Q; Prensner JR; Cao X; Singla N; Montie JE; Varambally S; Mehra R; Chinnaiyan AM
Cancer Res; 2008 Jan; 68(1):73-80. PubMed ID: 18172298
[TBL] [Abstract][Full Text] [Related]
12. Genome-wide analysis of alternative transcripts in human breast cancer.
Wen J; Toomer KH; Chen Z; Cai X
Breast Cancer Res Treat; 2015 Jun; 151(2):295-307. PubMed ID: 25913416
[TBL] [Abstract][Full Text] [Related]
13. Identification and characterization of novel fusion genes in prostate cancer by targeted RNA capture and next-generation sequencing.
Yang J; Chen Y; Lu J; Wang X; Wang L; Liang J; Sun ZS
Acta Biochim Biophys Sin (Shanghai); 2018 Nov; 50(11):1166-1172. PubMed ID: 30307468
[TBL] [Abstract][Full Text] [Related]
14. FLI1 is a novel ETS transcription factor involved in gene fusions in prostate cancer.
Paulo P; Barros-Silva JD; Ribeiro FR; Ramalho-Carvalho J; Jerónimo C; Henrique R; Lind GE; Skotheim RI; Lothe RA; Teixeira MR
Genes Chromosomes Cancer; 2012 Mar; 51(3):240-9. PubMed ID: 22081504
[TBL] [Abstract][Full Text] [Related]
15. Heterogeneity in the inter-tumor transcriptome of high risk prostate cancer.
Wyatt AW; Mo F; Wang K; McConeghy B; Brahmbhatt S; Jong L; Mitchell DM; Johnston RL; Haegert A; Li E; Liew J; Yeung J; Shrestha R; Lapuk AV; McPherson A; Shukin R; Bell RH; Anderson S; Bishop J; Hurtado-Coll A; Xiao H; Chinnaiyan AM; Mehra R; Lin D; Wang Y; Fazli L; Gleave ME; Volik SV; Collins CC
Genome Biol; 2014 Aug; 15(8):426. PubMed ID: 25155515
[TBL] [Abstract][Full Text] [Related]
16. Next-generation sequencing reveals novel rare fusion events with functional implication in prostate cancer.
Teles Alves I; Hartjes T; McClellan E; Hiltemann S; Böttcher R; Dits N; Temanni MR; Janssen B; van Workum W; van der Spek P; Stubbs A; de Klein A; Eussen B; Trapman J; Jenster G
Oncogene; 2015 Jan; 34(5):568-77. PubMed ID: 24488012
[TBL] [Abstract][Full Text] [Related]
17. Novel fusion transcripts in human gastric cancer revealed by transcriptome analysis.
Kim HP; Cho GA; Han SW; Shin JY; Jeong EG; Song SH; Lee WC; Lee KH; Bang D; Seo JS; Kim JI; Kim TY
Oncogene; 2014 Nov; 33(47):5434-41. PubMed ID: 24240688
[TBL] [Abstract][Full Text] [Related]
18. Distinct classes of chromosomal rearrangements create oncogenic ETS gene fusions in prostate cancer.
Tomlins SA; Laxman B; Dhanasekaran SM; Helgeson BE; Cao X; Morris DS; Menon A; Jing X; Cao Q; Han B; Yu J; Wang L; Montie JE; Rubin MA; Pienta KJ; Roulston D; Shah RB; Varambally S; Mehra R; Chinnaiyan AM
Nature; 2007 Aug; 448(7153):595-9. PubMed ID: 17671502
[TBL] [Abstract][Full Text] [Related]
19. The landscape and therapeutic relevance of cancer-associated transcript fusions.
Yoshihara K; Wang Q; Torres-Garcia W; Zheng S; Vegesna R; Kim H; Verhaak RG
Oncogene; 2015 Sep; 34(37):4845-54. PubMed ID: 25500544
[TBL] [Abstract][Full Text] [Related]
20. Chimeric transcript discovery by paired-end transcriptome sequencing.
Maher CA; Palanisamy N; Brenner JC; Cao X; Kalyana-Sundaram S; Luo S; Khrebtukova I; Barrette TR; Grasso C; Yu J; Lonigro RJ; Schroth G; Kumar-Sinha C; Chinnaiyan AM
Proc Natl Acad Sci U S A; 2009 Jul; 106(30):12353-8. PubMed ID: 19592507
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]